These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 1333300)

  • 1. Tumor necrosis factor and interleukin-1 induce expression of the verocytotoxin receptor globotriaosylceramide on human endothelial cells: implications for the pathogenesis of the hemolytic uremic syndrome.
    van de Kar NC; Monnens LA; Karmali MA; van Hinsbergh VW
    Blood; 1992 Dec; 80(11):2755-64. PubMed ID: 1333300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor necrosis factor and interleukin 1 induce expression of the glycolipid verotoxin receptor in human endothelial cells. Implications for the pathogenesis of the haemolytic uraemic syndrome.
    Van de Kar NC; Monnens LA; Van Hinsbergh VW
    Behring Inst Mitt; 1993 Aug; (92):202-9. PubMed ID: 8250811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor necrosis factor alpha induces endothelial galactosyl transferase activity and verocytotoxin receptors. Role of specific tumor necrosis factor receptors and protein kinase C.
    van de Kar NC; Kooistra T; Vermeer M; Lesslauer W; Monnens LA; van Hinsbergh VW
    Blood; 1995 Feb; 85(3):734-43. PubMed ID: 7530504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of verocytotoxin-1 on nonadherent human monocytes: binding characteristics, protein synthesis, and induction of cytokine release.
    van Setten PA; Monnens LA; Verstraten RG; van den Heuvel LP; van Hinsbergh VW
    Blood; 1996 Jul; 88(1):174-83. PubMed ID: 8704172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of TNF alpha on verocytotoxin cytotoxicity in purified human glomerular microvascular endothelial cells.
    van Setten PA; van Hinsbergh VW; van der Velden TJ; van de Kar NC; Vermeer M; Mahan JD; Assmann KJ; van den Heuvel LP; Monnens LA
    Kidney Int; 1997 Apr; 51(4):1245-56. PubMed ID: 9083293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Verocytotoxin inhibits mitogenesis and protein synthesis in purified human glomerular mesangial cells without affecting cell viability: evidence for two distinct mechanisms.
    Van Setten PA; van Hinsbergh VW; Van den Heuvel LP; van der Velden TJ; van de Kar NC; Krebbers RJ; Karmali MA; Monnens LA
    J Am Soc Nephrol; 1997 Dec; 8(12):1877-88. PubMed ID: 9402090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Verotoxin-1 promotes leukocyte adhesion to cultured endothelial cells under physiologic flow conditions.
    Morigi M; Micheletti G; Figliuzzi M; Imberti B; Karmali MA; Remuzzi A; Remuzzi G; Zoja C
    Blood; 1995 Dec; 86(12):4553-8. PubMed ID: 8541545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Shiga toxin-associated hemolytic uremic syndrome: interleukin-1 beta enhancement of Shiga toxin cytotoxicity toward human vascular endothelial cells in vitro.
    Kaye SA; Louise CB; Boyd B; Lingwood CA; Obrig TG
    Infect Immun; 1993 Sep; 61(9):3886-91. PubMed ID: 8359910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Shiga toxin-associated hemolytic-uremic syndrome: combined cytotoxic effects of Shiga toxin, interleukin-1 beta, and tumor necrosis factor alpha on human vascular endothelial cells in vitro.
    Louise CB; Obrig TG
    Infect Immun; 1991 Nov; 59(11):4173-9. PubMed ID: 1937774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human renal microvascular endothelial cells as a potential target in the development of the hemolytic uremic syndrome as related to fibrinolysis factor expression, in vitro.
    Louise CB; Obrig TG
    Microvasc Res; 1994 May; 47(3):377-87. PubMed ID: 8084301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Shiga toxin-associated hemolytic uremic syndrome: effect of sodium butyrate on sensitivity of human umbilical vein endothelial cells to Shiga toxin.
    Louise CB; Kaye SA; Boyd B; Lingwood CA; Obrig TG
    Infect Immun; 1995 Jul; 63(7):2766-9. PubMed ID: 7790096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Binding and transfer of verocytotoxin by polymorphonuclear leukocytes in hemolytic uremic syndrome.
    te Loo DM; Monnens LA; van Der Velden TJ; Vermeer MA; Preyers F; Demacker PN; van Den Heuvel LP; van Hinsbergh VW
    Blood; 2000 Jun; 95(11):3396-402. PubMed ID: 10828021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endothelial heterogeneity in Shiga toxin receptors and responses.
    Obrig TG; Louise CB; Lingwood CA; Boyd B; Barley-Maloney L; Daniel TO
    J Biol Chem; 1993 Jul; 268(21):15484-8. PubMed ID: 8340376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sensitization of human umbilical vein endothelial cells to Shiga toxin: involvement of protein kinase C and NF-kappaB.
    Louise CB; Tran MC; Obrig TG
    Infect Immun; 1997 Aug; 65(8):3337-44. PubMed ID: 9234795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Shiga toxin enhances functional tissue factor on human glomerular endothelial cells: implications for the pathophysiology of hemolytic uremic syndrome.
    Nestoridi E; Tsukurov O; Kushak RI; Ingelfinger JR; Grabowski EF
    J Thromb Haemost; 2005 Apr; 3(4):752-62. PubMed ID: 15842359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Verocytotoxin-induced apoptosis of human microvascular endothelial cells.
    Pijpers AHJM; Setten PAV; Heuvel LPWJVD; Assmann KJM; Dijkman HBPM; Pennings AHM; Monnens LAH; Hinsbergh VWMV
    J Am Soc Nephrol; 2001 Apr; 12(4):767-778. PubMed ID: 11274238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the effects of Shiga-like toxin 1 on cytokine- and butyrate-treated human umbilical and saphenous vein endothelial cells.
    Keusch GT; Acheson DW; Aaldering L; Erban J; Jacewicz MS
    J Infect Dis; 1996 May; 173(5):1164-70. PubMed ID: 8627068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor necrosis factor alpha increases human cerebral endothelial cell Gb3 and sensitivity to Shiga toxin.
    Eisenhauer PB; Chaturvedi P; Fine RE; Ritchie AJ; Pober JS; Cleary TG; Newburg DS
    Infect Immun; 2001 Mar; 69(3):1889-94. PubMed ID: 11179369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of Shiga toxins with human brain microvascular endothelial cells: cytokines as sensitizing agents.
    Ramegowda B; Samuel JE; Tesh VL
    J Infect Dis; 1999 Oct; 180(4):1205-13. PubMed ID: 10479149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The fibrinolytic system in the hemolytic uremic syndrome: in vivo and in vitro studies.
    van de Kar NC; van Hinsbergh VW; Brommer EJ; Monnens LA
    Pediatr Res; 1994 Aug; 36(2):257-64. PubMed ID: 7970942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.